FIELD TRIP HEALTH LTD (FTRP.CA) Stock Earnings & Estimates
Canada - TSX:FTRP - CA31656R1029 - Common Stock
3.74 CAD
+0.25 (+7.16%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 960K | 4.86M 406.26% | 18.185M 274.16% | 15.669M -13.83% | 34.814M 122.18% | 78.898M 126.63% | ||
| EBITDA YoY % growth | N/A | -17.7M | -49.439M -179.32% | -55.447M -12.15% | -90.102M -62.50% | -58.726M 34.82% | -39.041M 33.52% | |
| EBIT YoY % growth | -240K 4.00% | -19.09M -7,854.17% | -53.042M -177.85% | -62.463M -17.76% | -67.641M -8.29% | -56.466M 16.52% | -48.08M 14.85% | |
| Operating Margin | N/A | -1,988.54% | -1,091.37% | -343.49% | -431.68% | -162.19% | -60.94% | |
| EPS YoY % growth | N/A | N/A | -0.96 -98.14% | -1.16 -20.59% | -1.17 -1.32% | -1.03 12.15% | -0.92 10.40% |
All data in CAD
| Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.26 -10.87% | -0.27 -2.00% | -0.27 -6.08% | -0.27 -193.71% |
| Revenue Q2Q % growth | 5.587M 515.38% | 6.895M 406.70% | 8.159M 373.23% | 9.765M 116.95% |
| EBITDA Q2Q % growth | -12.552M 5.39% | -12.994M -10.20% | -13.314M -47.99% | -13.139M -2.11% |
| EBIT Q2Q % growth | -14.845M -0.78% | -15.349M -7.57% | -15.73M -24.85% | -15.615M -3.43% |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -0.09 58.96% | -0.26 | 0.16 | 64.59% |
| Q4 2022 Q2Q % growth | -0.25 -38.89% | -0.22 | -0.03 | -11.41% |
| Q3 2022 Q2Q % growth | -0.26 -18.18% | -0.20 | -0.06 | -27.45% |
| Q2 2022 Q2Q % growth | -0.23 -73.45% | -0.19 | -0.04 | -18.68% |
| Q1 2022 Q2Q % growth | -0.22 -65.91% | -0.25 | 0.03 | 11.96% |
| Q4 2021 Q2Q % growth | -0.18 -60.43% | -0.25 | 0.07 | 27.48% |
| Q3 2021 Q2Q % growth | -0.22 | -0.20 | -0.02 | -9.67% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | 418.94% | 4.501M | % | |
| Q4 2022 Q2Q % growth | 1.724M 225.30% | 3.245M | -1.521M | -46.86% |
| Q3 2022 Q2Q % growth | 1.361M 325.25% | 2.242M | -881.15K | -39.30% |
| Q2 2022 Q2Q % growth | 907.82K | 1.983M | -1.075M | -54.22% |
| Q1 2022 Q2Q % growth | 867.4K | 1.767M | -899.577K | -50.91% |
| Q4 2021 Q2Q % growth | 530K | 1.587M | -1.057M | -66.60% |
| Q3 2021 Q2Q % growth | 320K | 1.49M | -1.17M | -78.52% |
| Q2 2021 Q2Q % growth | 879.24K | -879.24K | -100.00% | |
| Q1 2021 Q2Q % growth | 545.19K | -545.19K | -100.00% | |
| Q4 2020 Q2Q % growth | 232.56K | -232.56K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |